CordycepsvsLion's Mane

Cordycepin (3'-deoxyadenosine), the primary bioactive compound, increases ATP production by enhancing mitochondrial electron transport chain efficiency — it may act as an alternative substrate or modulator of Complex I and Complex III. Cordycepin activates AMPK (AMP-activated protein kinase) via increased AMP/ATP ratio or direct activation of the alpha subunit, promoting glucose uptake through GLUT4 translocation and fatty acid oxidation via CPT-1 and ACC inhibition. Cordyceps increases erythropoietin (EPO) production, likely through HIF-1alpha stabilization in hypoxic-sensitive tissues, improving oxygen-carrying capacity. Cordycepin has adenosine-like activity, modulating purinergic P1 (A1, A2A, A2B, A3) and P2 receptors. Anti-inflammatory effects occur through inhibition of NF-kB (reducing IKK degradation of IkB and nuclear translocation) and reduction of pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). Adenosine deaminase-resistant cordycepin may also affect RNA polyadenylation.

Lion's Mane contains two classes of bioactive compounds: hericenones (A-H, found in the fruiting body) and erinacines (A-I, found in the mycelium). Both stimulate the synthesis of nerve growth factor (NGF) in astrocytes and neurons — hericenones may act through enhancement of NGF gene expression, while erinacines cross the blood-brain barrier and directly induce NGF. NGF binds to TrkA receptors and is essential for the survival, maintenance, and regeneration of cholinergic neurons, particularly in the hippocampus and basal forebrain. This promotes neurogenesis, dendritic arborization, and remyelination of nerve fibers. Lion's Mane also reduces neuroinflammation through inhibition of NF-κB signaling and suppression of pro-inflammatory cytokine production. It may enhance BDNF expression and support the gut-brain axis.